Tempus AI’s TEM stock has surged nearly 13% since its second-quarter 2025 earnings release. The quarter saw strong top-line ...

Tempus AI achieves strong revenue growth and beats expectations, but ongoing losses and execution risks temper enthusiasm.

The stock of Tempus AI (NASDAQ: TEM) gave back some of its gains after surging early in Friday's trading, but it still ended ...

Tempus AI TEM stock saw a positive improvement to its Relative Strength (RS) Rating on Thursday, rising from 66 to 78. Please ...

After Tempus AI’s Q2 earnings release, analysts at Morgan Stanley increased their price target on the stock from $65 to $68.

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting ...

Tempus AI shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.

Dan Ives' AI Revolution ETF (IVES) is heavily weighted toward big tech, betting these giants will lead the AI boom. Click ...

Ark Invest has six main ETFs with several around for more than 10 years. A look at the top 10 holdings across the six funds ...

In a report released on August 8, Subbu Nambi from Guggenheim reiterated a Buy rating on Tempus AI, Inc. Class A, with a price target of $75.00. The company’s shares closed last Friday at $60.87.

U.S. President Donald Trump launched a scathing attack on former House speaker Nancy Pelosi and her husband Paul Pelosi, on ...

President Trump blasted Rep. Nancy Pelosi as a “disgusting degenerate” while alleging that she and her hubby reaped a fortune ...